Adherence Rate of Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors

Not Applicable

Completed

• Conditions: Breast Cancer
• Interventions: Other: bubble packaging for monthly prescription

• Registration Number: NCT01694225
• Lead Sponsor: University of Louisville

Brief Summary

This study aims to establish the feasibility of using a monthly bubble package to improve compliance rates among women prescribed adjuvant endocrine therapy.

Detailed Description

This study uses Bubble packaging to provide a cost effective way to improve compliance and help direct further interventions to ensure adherence in women on anti-estrogen therapy for breast cancer.

Study Timeline

• Study Start: 2012-07
• Study First Submitted: 2012-09-23
• Study First Submitted QC: 2012-09-23
• Study First Posted: 2012-09-27
• Status Verified: 2017-12
• Primary Completion: 2018-01-28
• Study Completion: 2018-01-28
• Last Update Submitted: 2018-01-29
• Last Update Posted: 2018-01-31

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 87

Inclusion Criteria

• 18 years of age or older
• Estrogen receptor positive (> 1% estrogen expression) by immunohistochemistry
• Invasive breast cancer (stage I, II, III) or DCIS considered for adjuvant endocrine therapy

Exclusion Criteria

• Patients with metastatic disease (stage IV)
• Patients less than 18 years of age
• Prisoners
• Patients are unable to fill prescriptions at the BCC pharmacy due to insurance limitations or personal preference

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
bubble package for monthly prescription	bubble packaging for monthly prescription	use of bubble packaging for monthly prescription

Trial Locations

Locations (1)

James Graham Brown Cancer Center-University of Louisville; 🇺🇸 Louisville, Kentucky, United States